Hormone therapy for cancer in Istanbul, Turkey
Hormone therapy — also called endocrine therapy — slows or stops the growth of cancers that use hormones to grow, chiefly hormone-receptor-positive breast cancer and prostate cancer, by lowering hormone levels or blocking the body’s ability to use them. Because it only helps hormone-sensitive tumours, receptor testing on your own reports — ER and PR for breast cancer, and the prostate context — decides whether it applies at all. Istanbul hospitals offer this pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same drugs. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
What hormone therapy is
The U.S. National Cancer Institute describes hormone therapy — also called endocrine therapy — as treatment that slows or stops the growth of cancers that use hormones to grow. It works in one of two ways: by lowering the level of hormones in the body, or by blocking the cancer’s ability to use them. The two diagnoses it matters most for are hormone-receptor-positive breast cancer, which is driven by estrogen or progesterone, and prostate cancer, which is driven by androgens such as testosterone.
The central honest point is that hormone therapy only helps hormone-sensitive tumours. For breast cancer that is established by testing the tumour for the estrogen receptor (ER) and progesterone receptor (PR); the prostate context is assessed by your oncology team as well. That receptor status on your own pathology report is the gate that decides whether this treatment applies at all. Browse the wider cancer types hub for the breast and prostate diagnoses this most often applies to.
Treatment options
The forms of hormone therapy the NCI lists, and an honest note on each:
- Selective estrogen-receptor modulators (breast). Tamoxifen blocks estrogen from reaching hormone-receptor-positive breast-cancer cells and can be used before or after menopause. Whether it fits depends on your ER and PR receptor status, not a template.
- Aromatase inhibitors (breast). Anastrozole, letrozole and exemestane lower the estrogen the body makes and are used chiefly after menopause. They are taken as daily tablets, often for years, so cost scales with the length of the course.
- Androgen deprivation and anti-androgens (prostate). For prostate cancer, LHRH agonists or antagonists lower testosterone and anti-androgens block its effect on the cancer. Which is used, and for how long, is decided by your oncology team.
- Ovarian suppression & adjuvant use. In pre-menopausal breast cancer, suppressing the ovaries lowers estrogen; and hormone therapy is commonly given as adjuvant treatment for years after surgery to lower the risk of recurrence. Expect menopausal-type side effects — hot flushes and effects on bone density — which your team monitors.
See how these and other modalities work in general on the treatments & technology hub.
What it costs
There is no single hormone-therapy price, because it is usually a course of oral or injected drugs taken over months to years, so the cost is driven by which drug is used, the dose, and how long the course runs — plus the consultations, receptor testing and monitoring that go with it. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line — and you pay the hospital directly, never us. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling oncologists or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose medical-oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one treatment modality within the broader cancer treatment in Istanbul pillar, and it usually sits alongside surgery, chemotherapy or radiation rather than replacing them. If you want your own reports read first, a free second opinion organizes and verifies your pathology — including the receptor status that gates this treatment — into a plain-language case file in your language before you decide whether to travel.
Related treatments & diagnostics
Check everything here — us included
Common questions
Can I get hormone therapy in Turkey?
Yes. Istanbul hospitals provide the endocrine-therapy pathway the U.S. National Cancer Institute describes — tamoxifen or aromatase inhibitors such as anastrozole, letrozole or exemestane for hormone-receptor-positive breast cancer, ovarian suppression where it applies, and androgen deprivation therapy or anti-androgens for prostate cancer. These are usually oral or injected drugs taken over months to years, often as adjuvant treatment after surgery to lower the risk of recurrence. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your reports so the plan is understood before you travel.
Which cancers does hormone therapy treat?
Chiefly two. Per the NCI, hormone therapy works against cancers that use hormones to grow — most importantly hormone-receptor-positive breast cancer, which is driven by estrogen or progesterone, and prostate cancer, which is driven by androgens such as testosterone. It works either by lowering the level of those hormones in the body or by blocking the cancer's ability to use them. It does not help tumours that are hormone-receptor-negative, which is exactly why receptor testing comes first. A case review will flag whether your reports already establish the receptor status. This is general information, not a treatment recommendation.
Do I need receptor (ER/PR) testing first?
Yes — receptor testing is the gate. Hormone therapy only helps hormone-sensitive tumours, so the lab result on your own pathology report determines whether it applies at all. For breast cancer the tumour is tested for estrogen receptor (ER) and progesterone receptor (PR); a positive result means hormone therapy is likely to be part of the plan, while a negative one means it is not. The prostate context is assessed by your oncology team as well. A free case review reads your existing reports and tells you whether this testing has already been done, so you are not guessing before you travel.
How much does hormone therapy cost in Istanbul?
There is no single figure, because hormone therapy is usually a course of oral or injected drugs taken over months to years, so the cost is driven by which drug is used, the dose, and how long the course runs, plus the consultations and monitoring that go with it. Istanbul typically runs well below Western-European prices for the same drugs, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.